Emily C. Brock

810 total citations
17 papers, 624 citations indexed

About

Emily C. Brock is a scholar working on Immunology, Rheumatology and Surgery. According to data from OpenAlex, Emily C. Brock has authored 17 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Rheumatology and 5 papers in Surgery. Recurrent topics in Emily C. Brock's work include Mast cells and histamine (12 papers), Eosinophilic Esophagitis (5 papers) and Asthma and respiratory diseases (5 papers). Emily C. Brock is often cited by papers focused on Mast cells and histamine (12 papers), Eosinophilic Esophagitis (5 papers) and Asthma and respiratory diseases (5 papers). Emily C. Brock collaborates with scholars based in United States, Australia and Belgium. Emily C. Brock's co-authors include Bradford A. Youngblood, John Leung, Nenad Tomas̆ević, Christopher Bebbington, Rustom Falahati, Bruce S. Bochner, Julia Schanin, Wouter Korver, Alan Xu and Simon Gebremeskel and has published in prestigious journals such as Blood, Gastroenterology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Emily C. Brock

17 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily C. Brock United States 10 376 202 192 148 113 17 624
Julia Schanin United States 8 233 0.6× 87 0.4× 93 0.5× 63 0.4× 21 0.2× 18 349
Ruud A.J. Warringa Netherlands 12 195 0.5× 98 0.5× 382 2.0× 213 1.4× 92 0.8× 15 610
S Poto Italy 13 213 0.6× 56 0.3× 144 0.8× 186 1.3× 46 0.4× 23 515
Enza Vittori Italy 8 363 1.0× 35 0.2× 543 2.8× 181 1.2× 36 0.3× 8 836
Richard F. Horan United States 11 253 0.7× 216 1.1× 84 0.4× 224 1.5× 92 0.8× 17 489
R. Alam United States 11 360 1.0× 58 0.3× 208 1.1× 178 1.2× 35 0.3× 19 550
Erika Méndez-Enríquez Sweden 8 208 0.6× 27 0.1× 163 0.8× 81 0.5× 26 0.2× 15 390
Cheryl A. Hatfield United States 13 223 0.6× 47 0.2× 179 0.9× 137 0.9× 21 0.2× 15 456
Eugene W. Monroe United States 15 234 0.6× 617 3.1× 140 0.7× 212 1.4× 311 2.8× 32 917
Paul T.M. Kok Netherlands 11 202 0.5× 134 0.7× 342 1.8× 172 1.2× 18 0.2× 14 506

Countries citing papers authored by Emily C. Brock

Since Specialization
Citations

This map shows the geographic impact of Emily C. Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily C. Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily C. Brock more than expected).

Fields of papers citing papers by Emily C. Brock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily C. Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily C. Brock. The network helps show where Emily C. Brock may publish in the future.

Co-authorship network of co-authors of Emily C. Brock

This figure shows the co-authorship network connecting the top 25 collaborators of Emily C. Brock. A scholar is included among the top collaborators of Emily C. Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily C. Brock. Emily C. Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Benet, Zachary, et al.. (2024). MRGPRX2-Mediated Mast Cell Activation is a Shared Pathogenic Mechanism in Atopic Dermatitis and Prurigo Nodularis Patients that can be Therapeutically Targeted via Siglecs. Journal of Allergy and Clinical Immunology. 153(2). AB62–AB62. 1 indexed citations
2.
Benet, Zachary, Thuy Mai Luu, Emily C. Brock, et al.. (2023). An Agonistic Monoclonal Antibody Against Siglec-6 Broadly Inhibits Mast Cell Activation in Transgenic Mice. Journal of Allergy and Clinical Immunology. 151(2). AB168–AB168. 5 indexed citations
3.
Korver, Wouter, Simon Gebremeskel, Gian Luca Negri, et al.. (2022). The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation. Frontiers in Immunology. 13. 833728–833728. 27 indexed citations
4.
Schanin, Julia, Wouter Korver, Emily C. Brock, et al.. (2022). Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells. Communications Biology. 5(1). 1226–1226. 17 indexed citations
5.
Gebremeskel, Simon, Julia Schanin, Krysta M. Coyle, et al.. (2021). Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody. Frontiers in Immunology. 12. 650331–650331. 86 indexed citations
6.
Youngblood, Bradford A., John Leung, Rustom Falahati, et al.. (2020). Discovery, Function, and Therapeutic Targeting of Siglec-8. Cells. 10(1). 19–19. 62 indexed citations
7.
Brock, Emily C., Julia Schanin, Henrik Rasmussen, et al.. (2020). EoE Biopsies have Elevated and Activated Mast Cells that Produce Cytokines and Chemokines that Drive Disease Pathogenesis. Journal of Allergy and Clinical Immunology. 145(2). AB43–AB43. 1 indexed citations
8.
Youngblood, Bradford A., Tina Davis, Julia Schanin, et al.. (2020). Tu1251 MAST CELLS ARE SIGNIFICANTLY ACTIVATED IN PATIENTS WITH ULCERATIVE COLITIS AND ARE INHIBITED BY AN ANTI-SIGLEC-8 ANTIBODY, ANTOLIMAB (AK002). Gastroenterology. 158(6). S–1033. 1 indexed citations
9.
Schanin, Julia, Simon Gebremeskel, Wouter Korver, et al.. (2020). A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation. Mucosal Immunology. 14(2). 366–376. 60 indexed citations
10.
Kerr, Sheena C., Jeanmarie R. Gonzalez, Julia Schanin, et al.. (2020). An anti‐siglec‐8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells. Clinical & Experimental Allergy. 50(8). 904–914. 32 indexed citations
11.
Youngblood, Bradford A., Emily C. Brock, John Leung, et al.. (2019). AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice. International Archives of Allergy and Immunology. 180(2). 91–102. 84 indexed citations
12.
Walsh, Carolyn M., Rose Z. Hill, Jacques Deguine, et al.. (2019). Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. eLife. 8. 117 indexed citations
13.
Youngblood, Bradford A., Emily C. Brock, John Leung, et al.. (2019). Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight. 4(19). 79 indexed citations
14.
Legrand, Fanny, Yun Cao, Joshua B. Wechsler, et al.. (2018). Sialic acid–binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies. Journal of Allergy and Clinical Immunology. 143(6). 2227–2237.e10. 45 indexed citations
15.
Youngblood, Bradford A., Emily C. Brock, John Leung, Christopher Bebbington, & Nenad Tomas̆ević. (2018). 352 - AK002, a First-in-Class, Humanized, Non-Fucosylated IGG1 Siglec-8 Antibody, Selectively Depletes Blood and Tissue Eosinophils. Gastroenterology. 154(6). S–1358. 1 indexed citations
16.
Youngblood, Bradford A., Emily C. Brock, John Leung, Christopher Bebbington, & Nenad Tomas̆ević. (2018). 353 - Anti-Siglec-8 Antibody Reduces Eosinophil and Mast Cell Infiltration in a Mouse Model of Eosinophilic Gastritis: A Novel Therapeutic Approach for Eosinophilic Gastrointestinal Diseases. Gastroenterology. 154(6). S–1358. 2 indexed citations
17.
Youngblood, Bradford A., Emily C. Brock, John Leung, et al.. (2018). AK002, a Novel Humanized Monoclonal Antibody to Siglec-8, Inhibits Mast Cell Activity and Depletes Eosinophils in Ex Vivo Bone Marrow Tissue from Patients with Systemic Mastocytosis. Blood. 132(Supplement 1). 1104–1104. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Schanin Breakdown of academic impact, for papers by Ruud A.J. Warringa Breakdown of academic impact, for papers by S Poto Breakdown of academic impact, for papers by Enza Vittori Breakdown of academic impact, for papers by Richard F. Horan Breakdown of academic impact, for papers by R. Alam Breakdown of academic impact, for papers by Erika Méndez-Enríquez Breakdown of academic impact, for papers by Cheryl A. Hatfield Breakdown of academic impact, for papers by Eugene W. Monroe Breakdown of academic impact, for papers by Paul T.M. Kok
Rankless by CCL
2026